Page 114 - Read Online
P. 114

32.  Watson SP. Platelet activation by extracellular matrix proteins in   43.  DeLeo MJ 3rd, Gounis  MJ, Hong  B, Ford  JC, Wakhloo  AK,
              haemostasis and thrombosis. Curr Pharm Des 2009;15:1358‑72.  Bogdanov AA Jr. Carotid artery brain aneurysm model: in vivo
           33.  Wohner N. Role of cellular elements in thrombus formation and   molecular enzyme‑specific MR imaging of active inflammation in a
              dissolution. Cardiovasc Hematol Agents Med Chem 2008;6:224‑8.  pilot study. Radiology 2009;252:696‑703.
           34.  Fontaine  V, Touat  Z, Mtairag el M, Vranckx  R, Louedec  L,   44.  Hasan DM, Mahaney KB, Magnotta VA, Kung DK, Lawton MT,
              Houard  X, Andreassian  B, Sebbag  U, Palombi  T, Jacob  MP,   Hashimoto T, Winn HR, Saloner D, Martin A, Gahramanov S,
              Meilhac O, Michel JB. Role of leukocyte elastase in preventing   Dosa E, Neuwelt E, Young WL. Macrophage imaging within human
              cellular re‑colonization of the mural thrombus.  Am J Pathol   cerebral aneurysms wall using ferumoxytol‑enhanced MRI: a pilot
              2004;164:2077‑87.                                   study. Arterioscler Thromb Vasc Biol 2012;32:1032‑8.
           35.  Lee D, Yuki I, Murayama Y, Chiang A, Nishimura I, Vinters HV,   45.  Aoki T, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N. Simvastatin
              Wang  CJ, Nien  YL, Ishil  A, Wu  BM, Vinuela  F. Thrombus   suppresses  the  progression  of  experimentally  induced  cerebral
              organization and healing in the swine experimental aneurysm   aneurysms in rats. Stroke 2008;39:1276‑85.
              model. Part I. A histological and molecular analysis. J Neurosurg   46.  Aoki T, Kataoka H, Ishibashi R, Nakagami H, Nozaki K, Morishita R,
              2007;107:94‑108.                                    Hashimoto N. Pitavastatin suppresses formation and progression of
           36.  Chyatte  D, Bruno  G, Desai  S, Todor  DR. Inflammation and   cerebral aneurysms through inhibition of the nuclear factor kappaB
              intracranial aneurysms. Neurosurgery 1999;45:1137‑46.  pathway. Neurosurgery 2009;64:357‑65.
           37.  Krischek  B,  Kasuya  H,  Tajima  A,  Akagawa  H,  Sasaki  T,   47.  Tada Y, Kitazato KT, Yagi K, Shimada K, Matsushita N, Kinouchi T,
              Yoneyama  T, Ujiie  H, Kubo  O, Bonin  M, Takakura  K, Hori  T,   Kanematsu Y, Satomi J, Kageji T, Nagahiro S. Statins promote
              Inoue I. Network‑based gene expression analysis of intracranial   the growth of experimentally induced cerebral aneurysms in
              aneurysm tissue reveals role of antigen presenting cells. Neuroscience   estrogen‑deficient rats. Stroke 2011;42:2286‑93.
              2008;154:1398‑407.                              48.  Marbacher S, Schläppi JA, Fung C, Hüsler J, Beck J, Raabe A. Do
           38.  Shi  C, Awad  IA, Jafari  N, Lin  S, Du  P, Hage  ZA, Shenkar  R,   statins reduce the risk of aneurysm development? A case‑control
              Getch CC, Bredel M, Batjer HH, Bendok BR. Genomics of human   study. J Neurosurg 2012;116:638‑42.
              intracranial aneurysm wall. Stroke 2009;40:1252‑61.  49.  Aoki  T, Nishimura  M, Kataoka  H, Ishibashi  R, Nozaki  K,
           39.  Tulamo  R, Frösen J, Junnikkala  S, Paetau  A, Pitkäniemi J,   Hashimoto N. Reactive oxygen species modulate growth of cerebral
              Kangasniemi M, Niemela M, Jaaskelainen J, Jokitalo E, Karatas A,   aneurysms: a study using the free radical scavenger edaravone and
              Hernesniemi J, Meri S. Complement activation associates with   p47phox(‑/‑) mice. Lab Invest 2009;89:730‑41.
              saccular cerebral artery aneurysm wall degeneration and rupture.   50.  Hasan DM, Mahaney KB, Brown RD Jr, Meissner I, Piepgras DG,
              Neurosurgery 2006;59:1069‑76.                       Huston J, Capuano AW, Torner JC. Aspirin as a promising agent
           40.  Swartz RH, Bhuta SS, Farb RI, Agid R, Willinsky RA, Terbrugge KG,   for decreasing incidence of cerebral aneurysm rupture. Stroke
              Butany J, Wasserman BA, Johnstone DM, Silver FL, Mikulis DJ.   2011;42:3156‑62.
              Intracranial arterial wall imaging using high‑resolution 3‑tesla   51.  Gross  BA, Rosalind Lai  PM, Frerichs  KU, Du  R. Aspirin and
              contrast‑enhanced MRI. Neurology 2009;72:627‑34.    aneurysmal subarachnoid hemorrhage.  World Neurosurg
           41.  Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N,   2014;82:1127‑30.
              Johnstrom P, Davenport AP, Kirkpatrick PJ, Arch BN, Pickard JD,   52.  Chalouhi N, Jabbour P, Magnotta V, Hasan D. The emerging role of
              Weissberg  PL. Imaging atherosclerotic plaque  inflammation   ferumoxytol‑enhanced MRI in the management of cerebrovascular
              with  [18F]‑fluorodeoxyglucose positron emission tomography.   lesions. Molecules 2013;18:9670‑83.
              Circulation 2002;105:2708‑11.
           42.  Tawakol  A,  Migrino  RQ,  Bashian  GG,  Bedri  S,  Vermylen  D,
              Cury RC, Yates D, LaMuraglia GM, Furie K, Houser S, Gewirtz H,   Cite  this  article  as: Turkmani AH,  Edwards  NJ,  Chen  PR. The  role  of
              Muller JE, Brady TJ, Fischman AJ. In vivo 18F‑fluorodeoxyglucose   inflammation  in  cerebral  aneurysms.  Neuroimmunol  Neuroinflammation
                                                               2015;2(2):102-6.
              positron emission tomography imaging provides a noninvasive
              measure of carotid plaque inflammation in patients. J Am Coll   Source of Support: Nil. Conflict of Interest: No.
              Cardiol 2006;48:1818‑24.                         Received: 23-10-2014; Accepted: 12-12-2014



































            106                                              Neuroimmunol Neuroinflammation | Volume 2 | Issue 2 | April 15, 2015
   109   110   111   112   113   114   115   116   117   118   119